Clinical Trial of HG146 Administered to Subjects with Advanced Solid Tumors or Lymphoma

NCT04977167 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Lymphoma

Interventions

DRUG: HG146
DRUG: PD-(L)1 antibody

Sponsor

HitGen Inc.